CD36 is frequently acquired or amplified in CSCs of many cancer types, which is also associated with more aggressive tumor and poorer prognosis (Cancer Genome Atlas Research, 2015; Ladanyi et al., 2018). The gene discussed is CD36; the disease is cancer.